nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—ADRB2—prostate cancer	0.67	1	CbGaD
Esmolol—Acebutolol—SLC22A1—prostate cancer	0.000593	0.0706	CrCbGaD
Esmolol—Metipranolol—ADRB2—prostate cancer	0.000591	0.0704	CrCbGaD
Esmolol—Sotalol—ADRB2—prostate cancer	0.000527	0.0628	CrCbGaD
Esmolol—Chlorphenesin—CYP19A1—prostate cancer	0.000478	0.0569	CrCbGaD
Esmolol—Bevantolol—ADRB2—prostate cancer	0.000464	0.0553	CrCbGaD
Esmolol—Ibuprofen—BCL2—prostate cancer	0.000419	0.0499	CrCbGaD
Esmolol—Betaxolol—ADRB2—prostate cancer	0.000414	0.0493	CrCbGaD
Esmolol—Atenolol—ADRB2—prostate cancer	0.00041	0.0488	CrCbGaD
Esmolol—Bisoprolol—ADRB2—prostate cancer	0.000399	0.0476	CrCbGaD
Esmolol—Acebutolol—ADRB2—prostate cancer	0.000378	0.0451	CrCbGaD
Esmolol—Oxprenolol—ADRB2—prostate cancer	0.000376	0.0447	CrCbGaD
Esmolol—Alprenolol—ADRB2—prostate cancer	0.000343	0.0409	CrCbGaD
Esmolol—Ibuprofen—CXCL8—prostate cancer	0.000336	0.04	CrCbGaD
Esmolol—Metoprolol—ADRB2—prostate cancer	0.000319	0.038	CrCbGaD
Esmolol—Pindolol—ADRB2—prostate cancer	0.000295	0.0352	CrCbGaD
Esmolol—Metoprolol—CYP2C19—prostate cancer	0.000275	0.0327	CrCbGaD
Esmolol—Chlorphenesin—CYP3A4—prostate cancer	0.000224	0.0267	CrCbGaD
Esmolol—Chlorphenesin—PTGS2—prostate cancer	0.00022	0.0262	CrCbGaD
Esmolol—Bisoprolol—CYP3A4—prostate cancer	0.000219	0.026	CrCbGaD
Esmolol—Propranolol—CYP3A5—prostate cancer	0.000204	0.0243	CrCbGaD
Esmolol—Constipation—Mitoxantrone—prostate cancer	0.000168	0.000544	CcSEcCtD
Esmolol—Pain—Mitoxantrone—prostate cancer	0.000168	0.000544	CcSEcCtD
Esmolol—Angiopathy—Capecitabine—prostate cancer	0.000168	0.000543	CcSEcCtD
Esmolol—Bradycardia—Prednisone—prostate cancer	0.000167	0.000543	CcSEcCtD
Esmolol—Vomiting—Conjugated Estrogens—prostate cancer	0.000167	0.000542	CcSEcCtD
Esmolol—Urticaria—Estradiol—prostate cancer	0.000167	0.000542	CcSEcCtD
Esmolol—Mental disorder—Docetaxel—prostate cancer	0.000167	0.000542	CcSEcCtD
Esmolol—Body temperature increased—Estradiol—prostate cancer	0.000166	0.000539	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—prostate cancer	0.000166	0.000539	CcSEcCtD
Esmolol—Headache—Goserelin—prostate cancer	0.000166	0.000539	CcSEcCtD
Esmolol—Erythema—Docetaxel—prostate cancer	0.000166	0.000538	CcSEcCtD
Esmolol—Chills—Capecitabine—prostate cancer	0.000166	0.000537	CcSEcCtD
Esmolol—Headache—Conjugated Estrogens—prostate cancer	0.000165	0.000534	CcSEcCtD
Esmolol—Confusional state—Etoposide—prostate cancer	0.000164	0.000533	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—prostate cancer	0.000164	0.00053	CcSEcCtD
Esmolol—Dysgeusia—Docetaxel—prostate cancer	0.000163	0.000527	CcSEcCtD
Esmolol—Mental disorder—Capecitabine—prostate cancer	0.000162	0.000525	CcSEcCtD
Esmolol—Feeling abnormal—Mitoxantrone—prostate cancer	0.000162	0.000524	CcSEcCtD
Esmolol—Propranolol—ADRB2—prostate cancer	0.000161	0.0192	CrCbGaD
Esmolol—Erythema—Capecitabine—prostate cancer	0.000161	0.000521	CcSEcCtD
Esmolol—Skin disorder—Etoposide—prostate cancer	0.000158	0.000514	CcSEcCtD
Esmolol—Nausea—Goserelin—prostate cancer	0.000158	0.000511	CcSEcCtD
Esmolol—Hyperhidrosis—Etoposide—prostate cancer	0.000158	0.000511	CcSEcCtD
Esmolol—Ibuprofen—CYP2C19—prostate cancer	0.000157	0.0188	CrCbGaD
Esmolol—Dysgeusia—Capecitabine—prostate cancer	0.000157	0.00051	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—prostate cancer	0.000157	0.000508	CcSEcCtD
Esmolol—Nausea—Conjugated Estrogens—prostate cancer	0.000156	0.000506	CcSEcCtD
Esmolol—Urticaria—Mitoxantrone—prostate cancer	0.000156	0.000505	CcSEcCtD
Esmolol—Anorexia—Etoposide—prostate cancer	0.000155	0.000504	CcSEcCtD
Esmolol—Body temperature increased—Mitoxantrone—prostate cancer	0.000155	0.000502	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—prostate cancer	0.000154	0.000499	CcSEcCtD
Esmolol—Flushing—Prednisone—prostate cancer	0.000153	0.000495	CcSEcCtD
Esmolol—Hypotension—Etoposide—prostate cancer	0.000152	0.000494	CcSEcCtD
Esmolol—Asthenia—Estradiol—prostate cancer	0.000151	0.000489	CcSEcCtD
Esmolol—Dysuria—Epirubicin—prostate cancer	0.00015	0.000487	CcSEcCtD
Esmolol—Angiopathy—Prednisone—prostate cancer	0.000149	0.000484	CcSEcCtD
Esmolol—Syncope—Docetaxel—prostate cancer	0.000149	0.000483	CcSEcCtD
Esmolol—Pruritus—Estradiol—prostate cancer	0.000149	0.000483	CcSEcCtD
Esmolol—Paraesthesia—Etoposide—prostate cancer	0.000146	0.000475	CcSEcCtD
Esmolol—Loss of consciousness—Docetaxel—prostate cancer	0.000146	0.000473	CcSEcCtD
Esmolol—Dyspnoea—Etoposide—prostate cancer	0.000145	0.000471	CcSEcCtD
Esmolol—Somnolence—Etoposide—prostate cancer	0.000145	0.00047	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—prostate cancer	0.000145	0.00047	CcSEcCtD
Esmolol—Syncope—Capecitabine—prostate cancer	0.000144	0.000467	CcSEcCtD
Esmolol—Mental disorder—Prednisone—prostate cancer	0.000144	0.000467	CcSEcCtD
Esmolol—Convulsion—Docetaxel—prostate cancer	0.000144	0.000466	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—prostate cancer	0.000143	0.000465	CcSEcCtD
Esmolol—Erythema—Prednisone—prostate cancer	0.000143	0.000464	CcSEcCtD
Esmolol—Decreased appetite—Etoposide—prostate cancer	0.000142	0.00046	CcSEcCtD
Esmolol—Chest pain—Docetaxel—prostate cancer	0.000141	0.000458	CcSEcCtD
Esmolol—Loss of consciousness—Capecitabine—prostate cancer	0.000141	0.000458	CcSEcCtD
Esmolol—Gastrointestinal disorder—Etoposide—prostate cancer	0.000141	0.000456	CcSEcCtD
Esmolol—Asthenia—Mitoxantrone—prostate cancer	0.000141	0.000456	CcSEcCtD
Esmolol—Fatigue—Etoposide—prostate cancer	0.000141	0.000456	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—prostate cancer	0.00014	0.000455	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.00014	0.000455	CcSEcCtD
Esmolol—Pain—Etoposide—prostate cancer	0.000139	0.000452	CcSEcCtD
Esmolol—Constipation—Etoposide—prostate cancer	0.000139	0.000452	CcSEcCtD
Esmolol—Dizziness—Estradiol—prostate cancer	0.000139	0.000451	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—prostate cancer	0.000139	0.000451	CcSEcCtD
Esmolol—Propranolol—CYP2C19—prostate cancer	0.000139	0.0165	CrCbGaD
Esmolol—Dry mouth—Docetaxel—prostate cancer	0.000138	0.000448	CcSEcCtD
Esmolol—Propranolol—CYP1A1—prostate cancer	0.000138	0.0165	CrCbGaD
Esmolol—Chest pain—Capecitabine—prostate cancer	0.000137	0.000444	CcSEcCtD
Esmolol—Confusional state—Docetaxel—prostate cancer	0.000137	0.000443	CcSEcCtD
Esmolol—Anxiety—Capecitabine—prostate cancer	0.000136	0.000442	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000136	0.000441	CcSEcCtD
Esmolol—Oedema—Docetaxel—prostate cancer	0.000136	0.000439	CcSEcCtD
Esmolol—Feeling abnormal—Etoposide—prostate cancer	0.000134	0.000436	CcSEcCtD
Esmolol—Dry mouth—Capecitabine—prostate cancer	0.000134	0.000434	CcSEcCtD
Esmolol—Vomiting—Estradiol—prostate cancer	0.000134	0.000434	CcSEcCtD
Esmolol—Shock—Docetaxel—prostate cancer	0.000133	0.000432	CcSEcCtD
Esmolol—Nervous system disorder—Docetaxel—prostate cancer	0.000133	0.000431	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—prostate cancer	0.000133	0.00043	CcSEcCtD
Esmolol—Confusional state—Capecitabine—prostate cancer	0.000132	0.000429	CcSEcCtD
Esmolol—Headache—Estradiol—prostate cancer	0.000132	0.000427	CcSEcCtD
Esmolol—Skin disorder—Docetaxel—prostate cancer	0.000132	0.000427	CcSEcCtD
Esmolol—Agitation—Prednisone—prostate cancer	0.000132	0.000427	CcSEcCtD
Esmolol—Oedema—Capecitabine—prostate cancer	0.000131	0.000425	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—prostate cancer	0.000131	0.000425	CcSEcCtD
Esmolol—Angioedema—Prednisone—prostate cancer	0.000131	0.000424	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—prostate cancer	0.00013	0.000421	CcSEcCtD
Esmolol—Urticaria—Etoposide—prostate cancer	0.00013	0.00042	CcSEcCtD
Esmolol—Anorexia—Docetaxel—prostate cancer	0.000129	0.000419	CcSEcCtD
Esmolol—Shock—Capecitabine—prostate cancer	0.000129	0.000419	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—prostate cancer	0.000129	0.000418	CcSEcCtD
Esmolol—Body temperature increased—Etoposide—prostate cancer	0.000129	0.000418	CcSEcCtD
Esmolol—Propafenone—CYP3A4—prostate cancer	0.000129	0.0154	CrCbGaD
Esmolol—Nervous system disorder—Capecitabine—prostate cancer	0.000129	0.000417	CcSEcCtD
Esmolol—Syncope—Prednisone—prostate cancer	0.000128	0.000416	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—prostate cancer	0.000128	0.000414	CcSEcCtD
Esmolol—Skin disorder—Capecitabine—prostate cancer	0.000127	0.000413	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—prostate cancer	0.000127	0.000412	CcSEcCtD
Esmolol—Hyperhidrosis—Capecitabine—prostate cancer	0.000127	0.000411	CcSEcCtD
Esmolol—Hypotension—Docetaxel—prostate cancer	0.000127	0.000411	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—prostate cancer	0.000126	0.000409	CcSEcCtD
Esmolol—Loss of consciousness—Prednisone—prostate cancer	0.000126	0.000408	CcSEcCtD
Esmolol—Anorexia—Capecitabine—prostate cancer	0.000125	0.000405	CcSEcCtD
Esmolol—Nausea—Estradiol—prostate cancer	0.000125	0.000405	CcSEcCtD
Esmolol—Vomiting—Mitoxantrone—prostate cancer	0.000125	0.000404	CcSEcCtD
Esmolol—Convulsion—Prednisone—prostate cancer	0.000124	0.000402	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—prostate cancer	0.000124	0.000402	CcSEcCtD
Esmolol—Headache—Mitoxantrone—prostate cancer	0.000123	0.000398	CcSEcCtD
Esmolol—Hypotension—Capecitabine—prostate cancer	0.000123	0.000397	CcSEcCtD
Esmolol—Paraesthesia—Docetaxel—prostate cancer	0.000122	0.000395	CcSEcCtD
Esmolol—Anxiety—Prednisone—prostate cancer	0.000121	0.000394	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—prostate cancer	0.000121	0.000393	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000121	0.000393	CcSEcCtD
Esmolol—Dyspnoea—Docetaxel—prostate cancer	0.000121	0.000392	CcSEcCtD
Esmolol—Somnolence—Docetaxel—prostate cancer	0.00012	0.000391	CcSEcCtD
Esmolol—Flushing—Epirubicin—prostate cancer	0.000119	0.000387	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—prostate cancer	0.000119	0.000387	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—prostate cancer	0.000119	0.000387	CcSEcCtD
Esmolol—Dyspepsia—Docetaxel—prostate cancer	0.000119	0.000387	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—prostate cancer	0.000118	0.000383	CcSEcCtD
Esmolol—Paraesthesia—Capecitabine—prostate cancer	0.000118	0.000382	CcSEcCtD
Esmolol—Decreased appetite—Docetaxel—prostate cancer	0.000118	0.000382	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—prostate cancer	0.000118	0.000381	CcSEcCtD
Esmolol—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000117	0.000379	CcSEcCtD
Esmolol—Asthenia—Etoposide—prostate cancer	0.000117	0.000379	CcSEcCtD
Esmolol—Dyspnoea—Capecitabine—prostate cancer	0.000117	0.000379	CcSEcCtD
Esmolol—Oedema—Prednisone—prostate cancer	0.000117	0.000379	CcSEcCtD
Esmolol—Fatigue—Docetaxel—prostate cancer	0.000117	0.000379	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—prostate cancer	0.000117	0.000378	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—prostate cancer	0.000117	0.000378	CcSEcCtD
Esmolol—Nausea—Mitoxantrone—prostate cancer	0.000116	0.000378	CcSEcCtD
Esmolol—Pain—Docetaxel—prostate cancer	0.000116	0.000376	CcSEcCtD
Esmolol—Constipation—Docetaxel—prostate cancer	0.000116	0.000376	CcSEcCtD
Esmolol—Dyspepsia—Capecitabine—prostate cancer	0.000115	0.000374	CcSEcCtD
Esmolol—Chills—Epirubicin—prostate cancer	0.000115	0.000374	CcSEcCtD
Esmolol—Pruritus—Etoposide—prostate cancer	0.000115	0.000374	CcSEcCtD
Esmolol—Shock—Prednisone—prostate cancer	0.000115	0.000373	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—prostate cancer	0.000115	0.000372	CcSEcCtD
Esmolol—Nervous system disorder—Prednisone—prostate cancer	0.000115	0.000372	CcSEcCtD
Esmolol—Decreased appetite—Capecitabine—prostate cancer	0.000114	0.00037	CcSEcCtD
Esmolol—Skin disorder—Prednisone—prostate cancer	0.000114	0.000368	CcSEcCtD
Esmolol—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000113	0.000367	CcSEcCtD
Esmolol—Fatigue—Capecitabine—prostate cancer	0.000113	0.000367	CcSEcCtD
Esmolol—Hyperhidrosis—Prednisone—prostate cancer	0.000113	0.000366	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—prostate cancer	0.000113	0.000365	CcSEcCtD
Esmolol—Constipation—Capecitabine—prostate cancer	0.000112	0.000364	CcSEcCtD
Esmolol—Pain—Capecitabine—prostate cancer	0.000112	0.000364	CcSEcCtD
Esmolol—Erythema—Epirubicin—prostate cancer	0.000112	0.000363	CcSEcCtD
Esmolol—Feeling abnormal—Docetaxel—prostate cancer	0.000112	0.000362	CcSEcCtD
Esmolol—Anorexia—Prednisone—prostate cancer	0.000111	0.000361	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—prostate cancer	0.00011	0.000358	CcSEcCtD
Esmolol—Flushing—Doxorubicin—prostate cancer	0.00011	0.000358	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—prostate cancer	0.00011	0.000356	CcSEcCtD
Esmolol—Feeling abnormal—Capecitabine—prostate cancer	0.000108	0.000351	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—prostate cancer	0.000108	0.00035	CcSEcCtD
Esmolol—Dizziness—Etoposide—prostate cancer	0.000108	0.00035	CcSEcCtD
Esmolol—Body temperature increased—Docetaxel—prostate cancer	0.000107	0.000347	CcSEcCtD
Esmolol—Chills—Doxorubicin—prostate cancer	0.000107	0.000346	CcSEcCtD
Esmolol—Paraesthesia—Prednisone—prostate cancer	0.000105	0.00034	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—prostate cancer	0.000104	0.000338	CcSEcCtD
Esmolol—Urticaria—Capecitabine—prostate cancer	0.000104	0.000338	CcSEcCtD
Esmolol—Body temperature increased—Capecitabine—prostate cancer	0.000104	0.000336	CcSEcCtD
Esmolol—Vomiting—Etoposide—prostate cancer	0.000104	0.000336	CcSEcCtD
Esmolol—Erythema—Doxorubicin—prostate cancer	0.000104	0.000336	CcSEcCtD
Esmolol—Agitation—Epirubicin—prostate cancer	0.000103	0.000334	CcSEcCtD
Esmolol—Dyspepsia—Prednisone—prostate cancer	0.000103	0.000334	CcSEcCtD
Esmolol—Headache—Etoposide—prostate cancer	0.000102	0.000331	CcSEcCtD
Esmolol—Decreased appetite—Prednisone—prostate cancer	0.000102	0.000329	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—prostate cancer	0.000101	0.000329	CcSEcCtD
Esmolol—Fatigue—Prednisone—prostate cancer	0.000101	0.000327	CcSEcCtD
Esmolol—Syncope—Epirubicin—prostate cancer	0.0001	0.000326	CcSEcCtD
Esmolol—Constipation—Prednisone—prostate cancer	9.99e-05	0.000324	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—prostate cancer	9.84e-05	0.000319	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—prostate cancer	9.81e-05	0.0117	CrCbGaD
Esmolol—Asthenia—Docetaxel—prostate cancer	9.72e-05	0.000315	CcSEcCtD
Esmolol—Convulsion—Epirubicin—prostate cancer	9.7e-05	0.000315	CcSEcCtD
Esmolol—Nausea—Etoposide—prostate cancer	9.69e-05	0.000314	CcSEcCtD
Esmolol—Feeling abnormal—Prednisone—prostate cancer	9.63e-05	0.000312	CcSEcCtD
Esmolol—Pruritus—Docetaxel—prostate cancer	9.59e-05	0.000311	CcSEcCtD
Esmolol—Chest pain—Epirubicin—prostate cancer	9.54e-05	0.000309	CcSEcCtD
Esmolol—Agitation—Doxorubicin—prostate cancer	9.52e-05	0.000309	CcSEcCtD
Esmolol—Anxiety—Epirubicin—prostate cancer	9.5e-05	0.000308	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	9.47e-05	0.000307	CcSEcCtD
Esmolol—Asthenia—Capecitabine—prostate cancer	9.41e-05	0.000305	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—prostate cancer	9.33e-05	0.000302	CcSEcCtD
Esmolol—Syncope—Doxorubicin—prostate cancer	9.29e-05	0.000301	CcSEcCtD
Esmolol—Urticaria—Prednisone—prostate cancer	9.28e-05	0.000301	CcSEcCtD
Esmolol—Pruritus—Capecitabine—prostate cancer	9.28e-05	0.000301	CcSEcCtD
Esmolol—Body temperature increased—Prednisone—prostate cancer	9.24e-05	0.0003	CcSEcCtD
Esmolol—Confusional state—Epirubicin—prostate cancer	9.22e-05	0.000299	CcSEcCtD
Esmolol—Oedema—Epirubicin—prostate cancer	9.14e-05	0.000296	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—prostate cancer	9.11e-05	0.000295	CcSEcCtD
Esmolol—Shock—Epirubicin—prostate cancer	8.99e-05	0.000292	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—prostate cancer	8.98e-05	0.000291	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—prostate cancer	8.96e-05	0.000291	CcSEcCtD
Esmolol—Dizziness—Docetaxel—prostate cancer	8.96e-05	0.000291	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—prostate cancer	8.88e-05	0.000288	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—prostate cancer	8.84e-05	0.000286	CcSEcCtD
Esmolol—Propranolol—CYP3A4—prostate cancer	8.82e-05	0.0105	CrCbGaD
Esmolol—Chest pain—Doxorubicin—prostate cancer	8.82e-05	0.000286	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—prostate cancer	8.79e-05	0.000285	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.76e-05	0.000284	CcSEcCtD
Esmolol—Anorexia—Epirubicin—prostate cancer	8.71e-05	0.000282	CcSEcCtD
Esmolol—Dizziness—Capecitabine—prostate cancer	8.68e-05	0.000281	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—prostate cancer	8.63e-05	0.00028	CcSEcCtD
Esmolol—Vomiting—Docetaxel—prostate cancer	8.62e-05	0.000279	CcSEcCtD
Esmolol—Hypotension—Epirubicin—prostate cancer	8.54e-05	0.000277	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—prostate cancer	8.53e-05	0.000276	CcSEcCtD
Esmolol—Headache—Docetaxel—prostate cancer	8.49e-05	0.000275	CcSEcCtD
Esmolol—Oedema—Doxorubicin—prostate cancer	8.46e-05	0.000274	CcSEcCtD
Esmolol—Asthenia—Prednisone—prostate cancer	8.39e-05	0.000272	CcSEcCtD
Esmolol—Vomiting—Capecitabine—prostate cancer	8.34e-05	0.00027	CcSEcCtD
Esmolol—Shock—Doxorubicin—prostate cancer	8.32e-05	0.00027	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—prostate cancer	8.29e-05	0.000269	CcSEcCtD
Esmolol—Pruritus—Prednisone—prostate cancer	8.27e-05	0.000268	CcSEcCtD
Esmolol—Headache—Capecitabine—prostate cancer	8.22e-05	0.000266	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—prostate cancer	8.22e-05	0.000266	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—prostate cancer	8.21e-05	0.000266	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—prostate cancer	8.18e-05	0.000265	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—prostate cancer	8.15e-05	0.000264	CcSEcCtD
Esmolol—Somnolence—Epirubicin—prostate cancer	8.13e-05	0.000263	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—prostate cancer	8.06e-05	0.000261	CcSEcCtD
Esmolol—Nausea—Docetaxel—prostate cancer	8.05e-05	0.000261	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—prostate cancer	8.05e-05	0.000261	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—prostate cancer	7.95e-05	0.000258	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—prostate cancer	7.9e-05	0.000256	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—prostate cancer	7.89e-05	0.000256	CcSEcCtD
Esmolol—Fatigue—Epirubicin—prostate cancer	7.88e-05	0.000255	CcSEcCtD
Esmolol—Pain—Epirubicin—prostate cancer	7.82e-05	0.000253	CcSEcCtD
Esmolol—Constipation—Epirubicin—prostate cancer	7.82e-05	0.000253	CcSEcCtD
Esmolol—Nausea—Capecitabine—prostate cancer	7.79e-05	0.000253	CcSEcCtD
Esmolol—Dizziness—Prednisone—prostate cancer	7.73e-05	0.000251	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—prostate cancer	7.59e-05	0.000246	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—prostate cancer	7.54e-05	0.000244	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—prostate cancer	7.53e-05	0.000244	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—prostate cancer	7.52e-05	0.000244	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—prostate cancer	7.45e-05	0.000241	CcSEcCtD
Esmolol—Vomiting—Prednisone—prostate cancer	7.43e-05	0.000241	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—prostate cancer	7.35e-05	0.000238	CcSEcCtD
Esmolol—Headache—Prednisone—prostate cancer	7.32e-05	0.000237	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.3e-05	0.000237	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—prostate cancer	7.29e-05	0.000236	CcSEcCtD
Esmolol—Urticaria—Epirubicin—prostate cancer	7.26e-05	0.000235	CcSEcCtD
Esmolol—Pain—Doxorubicin—prostate cancer	7.23e-05	0.000234	CcSEcCtD
Esmolol—Constipation—Doxorubicin—prostate cancer	7.23e-05	0.000234	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—prostate cancer	7.23e-05	0.000234	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—prostate cancer	6.97e-05	0.000226	CcSEcCtD
Esmolol—Nausea—Prednisone—prostate cancer	6.94e-05	0.000225	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—prostate cancer	6.72e-05	0.000218	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—prostate cancer	6.69e-05	0.000217	CcSEcCtD
Esmolol—Asthenia—Epirubicin—prostate cancer	6.56e-05	0.000213	CcSEcCtD
Esmolol—Pruritus—Epirubicin—prostate cancer	6.47e-05	0.00021	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—prostate cancer	6.07e-05	0.000197	CcSEcCtD
Esmolol—Dizziness—Epirubicin—prostate cancer	6.04e-05	0.000196	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—prostate cancer	5.98e-05	0.000194	CcSEcCtD
Esmolol—Vomiting—Epirubicin—prostate cancer	5.81e-05	0.000188	CcSEcCtD
Esmolol—Headache—Epirubicin—prostate cancer	5.73e-05	0.000186	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—prostate cancer	5.59e-05	0.000181	CcSEcCtD
Esmolol—Nausea—Epirubicin—prostate cancer	5.43e-05	0.000176	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—prostate cancer	5.38e-05	0.000174	CcSEcCtD
Esmolol—Headache—Doxorubicin—prostate cancer	5.3e-05	0.000172	CcSEcCtD
Esmolol—Nausea—Doxorubicin—prostate cancer	5.02e-05	0.000163	CcSEcCtD
Esmolol—ADRB2—Signaling Pathways—RALBP1—prostate cancer	1.55e-05	0.00119	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PTHLH—prostate cancer	1.54e-05	0.00118	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKACB—prostate cancer	1.51e-05	0.00116	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PTHLH—prostate cancer	1.51e-05	0.00115	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CALCA—prostate cancer	1.5e-05	0.00114	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKACB—prostate cancer	1.48e-05	0.00113	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PPP3CA—prostate cancer	1.47e-05	0.00113	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CALCA—prostate cancer	1.46e-05	0.00112	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCL12—prostate cancer	1.46e-05	0.00112	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ANXA1—prostate cancer	1.45e-05	0.00111	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PPP3CA—prostate cancer	1.44e-05	0.0011	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCL12—prostate cancer	1.43e-05	0.00109	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ANXA1—prostate cancer	1.42e-05	0.00109	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PENK—prostate cancer	1.42e-05	0.00108	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	1.41e-05	0.00108	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PENK—prostate cancer	1.38e-05	0.00106	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	1.38e-05	0.00105	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CALCA—prostate cancer	1.36e-05	0.00104	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GHR—prostate cancer	1.35e-05	0.00103	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PRKCQ—prostate cancer	1.33e-05	0.00102	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CALCA—prostate cancer	1.33e-05	0.00102	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCL12—prostate cancer	1.33e-05	0.00102	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GHR—prostate cancer	1.32e-05	0.00101	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PRKCQ—prostate cancer	1.31e-05	0.000998	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCL12—prostate cancer	1.3e-05	0.000993	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NRP1—prostate cancer	1.29e-05	0.00099	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NRP1—prostate cancer	1.27e-05	0.000968	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRB2—prostate cancer	1.25e-05	0.000959	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—VAV3—prostate cancer	1.22e-05	0.000935	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKCQ—prostate cancer	1.21e-05	0.000926	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GNRH1—prostate cancer	1.2e-05	0.00092	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VIP—prostate cancer	1.2e-05	0.00092	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—VAV3—prostate cancer	1.2e-05	0.000915	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ITPR1—prostate cancer	1.19e-05	0.000907	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKCQ—prostate cancer	1.19e-05	0.000906	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GNRH1—prostate cancer	1.18e-05	0.0009	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VIP—prostate cancer	1.18e-05	0.0009	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GRP—prostate cancer	1.17e-05	0.000891	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LPAR1—prostate cancer	1.17e-05	0.000891	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ITPR1—prostate cancer	1.16e-05	0.000887	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLCB2—prostate cancer	1.15e-05	0.000882	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LRP2—prostate cancer	1.15e-05	0.000882	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LPAR1—prostate cancer	1.14e-05	0.000872	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GRP—prostate cancer	1.14e-05	0.000872	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRB2—prostate cancer	1.14e-05	0.000871	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—P4HB—prostate cancer	1.13e-05	0.000865	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CX3CL1—prostate cancer	1.13e-05	0.000865	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLCB2—prostate cancer	1.13e-05	0.000863	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LRP2—prostate cancer	1.13e-05	0.000863	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—VAV3—prostate cancer	1.11e-05	0.000849	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HIST1H2BG—prostate cancer	1.11e-05	0.000849	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CX3CL1—prostate cancer	1.11e-05	0.000846	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—P4HB—prostate cancer	1.11e-05	0.000846	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GRB7—prostate cancer	1.1e-05	0.000842	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDE4D—prostate cancer	1.1e-05	0.000842	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—VAV3—prostate cancer	1.09e-05	0.000831	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HIST1H2BG—prostate cancer	1.09e-05	0.000831	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ITPR1—prostate cancer	1.08e-05	0.000824	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDE4D—prostate cancer	1.08e-05	0.000823	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GRB7—prostate cancer	1.08e-05	0.000823	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HIST1H4H—prostate cancer	1.07e-05	0.00082	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CXCL8—prostate cancer	1.07e-05	0.00082	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ITPR1—prostate cancer	1.05e-05	0.000806	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HIST1H4H—prostate cancer	1.05e-05	0.000802	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CXCL8—prostate cancer	1.05e-05	0.000802	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GNG5—prostate cancer	1.05e-05	0.000801	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GNG5—prostate cancer	1.02e-05	0.000783	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFBR1—prostate cancer	9.12e-06	0.000697	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTHLH—prostate cancer	9.12e-06	0.000697	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKR1C3—prostate cancer	8.97e-06	0.000686	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKACB—prostate cancer	8.93e-06	0.000682	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTHLH—prostate cancer	8.92e-06	0.000682	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFBR1—prostate cancer	8.92e-06	0.000682	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	8.78e-06	0.000671	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKACB—prostate cancer	8.73e-06	0.000668	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PPP3CA—prostate cancer	8.7e-06	0.000665	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—THBS1—prostate cancer	8.7e-06	0.000665	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ANXA1—prostate cancer	8.58e-06	0.000656	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—THBS1—prostate cancer	8.51e-06	0.000651	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	8.51e-06	0.000651	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCZ—prostate cancer	8.42e-06	0.000644	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ANXA1—prostate cancer	8.39e-06	0.000641	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	8.24e-06	0.00063	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CG—prostate cancer	8.23e-06	0.000629	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGFR4—prostate cancer	8.13e-06	0.000622	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PARP1—prostate cancer	8.13e-06	0.000622	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	8.05e-06	0.000615	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CALCA—prostate cancer	8.03e-06	0.000614	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PARP1—prostate cancer	7.95e-06	0.000608	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGFR4—prostate cancer	7.95e-06	0.000608	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CALCA—prostate cancer	7.86e-06	0.000601	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL12—prostate cancer	7.84e-06	0.0006	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL12—prostate cancer	7.67e-06	0.000587	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CG—prostate cancer	7.47e-06	0.000571	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CASP9—prostate cancer	7.39e-06	0.000565	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	7.31e-06	0.000559	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CD—prostate cancer	7.23e-06	0.000553	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CASP9—prostate cancer	7.23e-06	0.000552	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCQ—prostate cancer	7.16e-06	0.000547	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NGFR—prostate cancer	7.16e-06	0.000547	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	7.08e-06	0.000541	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAP3K7—prostate cancer	7.07e-06	0.000541	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	7e-06	0.000535	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NGFR—prostate cancer	7e-06	0.000535	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	6.92e-06	0.000529	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF10—prostate cancer	6.8e-06	0.00052	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB2—prostate cancer	6.73e-06	0.000515	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF10—prostate cancer	6.65e-06	0.000509	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—JAK2—prostate cancer	6.64e-06	0.000508	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MAP2K1—prostate cancer	6.61e-06	0.000506	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CD—prostate cancer	6.57e-06	0.000502	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VAV3—prostate cancer	6.56e-06	0.000502	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	6.49e-06	0.000496	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFBR2—prostate cancer	6.47e-06	0.000495	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	6.47e-06	0.000495	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	6.43e-06	0.000491	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VAV3—prostate cancer	6.42e-06	0.000491	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ITPR1—prostate cancer	6.37e-06	0.000487	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	6.33e-06	0.000484	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CB—prostate cancer	6.31e-06	0.000482	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ITPR1—prostate cancer	6.23e-06	0.000476	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	6.17e-06	0.000472	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1R—prostate cancer	6.09e-06	0.000465	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	6.06e-06	0.000463	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—JAK2—prostate cancer	6.03e-06	0.000461	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1R—prostate cancer	5.95e-06	0.000455	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	5.93e-06	0.000453	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—JAK2—prostate cancer	5.9e-06	0.000451	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LPL—prostate cancer	5.84e-06	0.000446	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—IL2—prostate cancer	5.79e-06	0.000443	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	5.78e-06	0.000442	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	5.73e-06	0.000438	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LPL—prostate cancer	5.71e-06	0.000436	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	5.66e-06	0.000433	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	5.66e-06	0.000432	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	5.64e-06	0.000431	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	5.6e-06	0.000428	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	5.51e-06	0.000421	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	5.5e-06	0.000421	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	5.47e-06	0.000418	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	5.46e-06	0.000417	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	5.38e-06	0.000411	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	5.35e-06	0.000409	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	5.34e-06	0.000408	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL2—prostate cancer	5.26e-06	0.000402	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TERT—prostate cancer	5.24e-06	0.000401	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	5.14e-06	0.000393	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TERT—prostate cancer	5.13e-06	0.000392	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	5.01e-06	0.000383	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	4.9e-06	0.000375	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LEP—prostate cancer	4.89e-06	0.000374	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	4.85e-06	0.00037	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KDR—prostate cancer	4.79e-06	0.000366	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LEP—prostate cancer	4.78e-06	0.000366	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	4.74e-06	0.000362	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KDR—prostate cancer	4.69e-06	0.000358	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	4.67e-06	0.000357	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	4.57e-06	0.000349	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—BAD—prostate cancer	4.56e-06	0.000348	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—BAD—prostate cancer	4.46e-06	0.000341	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APC—prostate cancer	4.41e-06	0.000337	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	4.41e-06	0.000337	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGF—prostate cancer	4.36e-06	0.000334	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	4.36e-06	0.000334	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APC—prostate cancer	4.32e-06	0.00033	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	4.32e-06	0.00033	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGF—prostate cancer	4.27e-06	0.000326	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	4.27e-06	0.000326	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	4.24e-06	0.000324	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INS—prostate cancer	4.18e-06	0.000319	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	4.14e-06	0.000317	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	4.09e-06	0.000313	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INS—prostate cancer	4.09e-06	0.000312	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	4.04e-06	0.000309	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	4.02e-06	0.000307	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	4e-06	0.000306	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	3.95e-06	0.000302	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	3.93e-06	0.000301	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	3.91e-06	0.000299	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	3.88e-06	0.000297	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	3.84e-06	0.000294	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	3.84e-06	0.000293	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	3.82e-06	0.000292	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	3.8e-06	0.00029	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	3.8e-06	0.00029	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	3.76e-06	0.000287	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	3.75e-06	0.000287	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	3.72e-06	0.000284	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	3.72e-06	0.000284	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	3.66e-06	0.00028	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	3.63e-06	0.000278	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	3.58e-06	0.000274	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	3.56e-06	0.000272	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	3.49e-06	0.000267	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	3.48e-06	0.000266	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	3.48e-06	0.000266	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	3.43e-06	0.000262	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	3.41e-06	0.000261	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	3.4e-06	0.00026	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	3.38e-06	0.000259	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	3.35e-06	0.000256	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	3.31e-06	0.000253	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	3.25e-06	0.000248	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	3.18e-06	0.000243	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	3.17e-06	0.000243	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	3.14e-06	0.00024	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	3.11e-06	0.000238	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL2—prostate cancer	3.11e-06	0.000237	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	3.11e-06	0.000237	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	3.09e-06	0.000236	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	3.07e-06	0.000235	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	3.04e-06	0.000233	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL2—prostate cancer	3.04e-06	0.000232	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	3.03e-06	0.000232	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	3.02e-06	0.000231	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	3e-06	0.000229	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	2.96e-06	0.000226	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	2.94e-06	0.000225	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	2.93e-06	0.000224	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	2.93e-06	0.000224	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	2.92e-06	0.000223	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	2.88e-06	0.00022	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	2.87e-06	0.000219	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	2.86e-06	0.000219	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	2.85e-06	0.000218	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	2.79e-06	0.000213	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EP300—prostate cancer	2.79e-06	0.000213	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EP300—prostate cancer	2.73e-06	0.000208	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SRC—prostate cancer	2.71e-06	0.000207	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SRC—prostate cancer	2.65e-06	0.000203	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	2.64e-06	0.000202	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	2.61e-06	0.0002	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	2.58e-06	0.000197	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	2.56e-06	0.000195	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MYC—prostate cancer	2.43e-06	0.000186	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	2.42e-06	0.000185	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MYC—prostate cancer	2.38e-06	0.000182	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	2.38e-06	0.000182	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	2.37e-06	0.000181	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	2.32e-06	0.000178	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	2.24e-06	0.000172	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	2.2e-06	0.000168	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	2.06e-06	0.000158	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	2.02e-06	0.000154	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TP53—prostate cancer	1.99e-06	0.000153	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TP53—prostate cancer	1.95e-06	0.000149	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—prostate cancer	1.83e-06	0.00014	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—prostate cancer	1.79e-06	0.000137	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	1.68e-06	0.000129	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	1.65e-06	0.000126	CbGpPWpGaD
